Legal dispute on government's improper cut of insurance drug prices still flared up

Published: 2002-10-01 06:58:00

Updated: 2002-10-01 06:58:00

In line with the recent administrative suit to suspend the improper reduction of insurance drug prices in a high court following the previous injunction trial at the end of last month, the Ministry of Health and Welfare is currently concentrating their efforts to win the case in a high court thro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK